Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 30th, there was short interest totaling 49,980 shares, a decrease of 53.4% from the January 15th total of 107,279 shares. Based on an average daily volume of 7,302,732 shares, the short-interest ratio is presently 0.0 days. Currently, 6.8% of the company’s stock are sold short. Currently, 6.8% of the company’s stock are sold short. Based on an average daily volume of 7,302,732 shares, the short-interest ratio is presently 0.0 days.
Aditxt Stock Performance
Shares of NASDAQ:ADTX opened at $0.69 on Thursday. The firm has a market cap of $505,160.00, a P/E ratio of 0.00 and a beta of 1.49. Aditxt has a 52-week low of $0.58 and a 52-week high of $4,463.50. The business’s 50 day simple moving average is $1.22 and its two-hundred day simple moving average is $46.88.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Aditxt in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.
About Aditxt
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
Read More
- Five stocks we like better than Aditxt
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Trump’s Hand-Written Letter Will Shock his Haters
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
